Piramal Pharma Profit & Loss Annual

Trade
BSE: 543635 | NSE: PPLPHARMA | ISIN: INE0DK501011 | Sector: -
249.75 -0.15 (-0.06%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 8,171.167,081.556,559.102,938.81
Total Revenue 8,171.167,081.556,559.102,938.81
Costof Revenue Total 3,195.592,911.112,614.801,227.76
Gross Profit 4,975.574,170.443,944.301,711.05
Selling/ General/ Admin Expenses Total 2,634.672,416.271,997.50456.69
Research Development 1,006.70863.601,283.40691.40
Depreciation/ Amortization 740.57676.69586.18143.64
Unusual Expense( Income) 62.796.9615.08-
Other Operating Expenses Total -50.92-159.77-77.00-52.40
Total Operating Expense 6,683.375,937.625,264.901,844.83
Operating Income 1,487.791,143.931,294.201,093.98
Interest Inc( Exp) Net- Non- Op Total 1,053.40520.20733.701,452.40
Gain( Loss)on Saleof Assets -4.60-4.80-5.403.30
Other Net -1,413.38-1,315.62-882.05-552.77
Net Income Before Taxes 179.29-120.15484.98686.78
Provisionfor Income Taxes 161.4766.31109.02115.28
Net Income After Taxes 17.82-186.46375.96571.50
Net Income Before Extra Items 17.82-186.46375.96571.50
Net Income 17.82-186.46375.96571.50
Income Availableto Com Excl Extra Ord 17.82-186.46375.96571.50
Income Availableto Com Incl Extra Ord 17.82-186.46375.96571.50
Diluted Net Income 17.82-186.46375.96571.50
Diluted Weighted Average Shares 128.11121.87120.72121.44
Diluted EPS Excluding Extra Ord Items 0.14-1.533.114.71
DPS- Common Stock Primary Issue 0.11-0.000.00
Diluted Normalized EPS 0.46-1.493.214.70
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts